Wellcome Leap Psilocybin for OUD

NCT06786325 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Psilocybin

Sponsor

Anna Rose Childress, Ph.D.